Affiliate disclosure: some links on this page are affiliate links and may earn us a commission at no extra cost to you — it never affects our rankings or reviews.

Wellmedr vs MEDVi (2026): Price and Pharmacies Compared

Edited by Gabriel BrocklesbyFounder & EditorFact-checked

Wellmedr advertises compounded semaglutide at $49 a month and tirzepatide at $89 a month during a fall sale, an advertised sale price that changes (checked 6 October 2026). MEDVi names its partner pharmacies and has an FDA warning letter on record.

Compare Wellmedr and MEDVi on price, medicines, pharmacies, cancellation and regulatory record, using only what our own reviews record and the dates they were checked. Where a detail is not stated on a site, this page says so.

Quick intro

People compare Wellmedr and MEDVi because both sell compounded GLP-1 treatment online, at different prices and with different levels of published detail. Everything below comes from our own Wellmedr and MEDVi reviews, with the date each figure was checked. Wellmedr is shown as welludr. on its sign-up page.

Quick Comparison Summary

  • Wellmedr advertises compounded semaglutide at $49 a month and tirzepatide at $89 a month during a fall sale, an advertised sale price whose plan cards say "Starting At" (checked 6 October 2026).
  • MEDVi names three partner compounding pharmacies and publishes a cancellation and refund policy; Wellmedr does not name its pharmacy on its sign-up page.
  • On 20 February 2026 the FDA issued warning letter 721455 to MEDVi over the labelling and marketing of its compounded GLP-1 products. Our Wellmedr review records no FDA letter.
  • Compounded medications are not FDA approved and are not evaluated by the FDA for safety or effectiveness.
  • A licensed clinician reviews your intake and decides whether treatment is appropriate for you.
  • Welludr LLC provides technology and non-clinical administrative support; a licensed clinician makes all diagnosis and prescribing decisions using independent clinical judgment; a prescription is never guaranteed.
  • Semaglutide and tirzepatide carry a boxed warning for the risk of thyroid C-cell tumours, including medullary thyroid carcinoma. They are not suitable if you or a close relative have had medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2), so tell the clinician about that history.
  • Wellmedr is for people in the US only, and eligibility is checked at sign-up.

Provider cards

Compare the two providers side by side using the same summary format used across the site.

Wellmedr

An online programme offering compounded semaglutide and tirzepatide through a short quiz and clinician review.

Best for: People who want a published starting price and monthly plans that can be cancelled or changed anytime

  • Compounded semaglutide $49/month and tirzepatide $89/month during a sale, plan cards say Starting At (checked 6 Oct 2026)
  • Monthly plans can be cancelled or changed anytime
  • Messaging with clinicians and free discreet shipping included
Visit provider site

MEDVi

An accessible GLP-1 provider option for users who want a straightforward path into treatment comparison without a high-friction intake process.

Best for: Users who want an accessible GLP-1 option

  • Accessible entry point
  • GLP-1-focused option
  • Simple comparison path
Visit provider site
CategoryWellmedrMEDVi
Advertised priceCompounded semaglutide at $49 a month and compounded tirzepatide at $89 a month during a fall sale, an advertised sale price (checked 6 October 2026). The plan cards say "Starting At".Compounded GLP-1 injections from $179 a month and compounded GLP-1 tablets from $249 a month (checked 16 September 2026). The $179 figure appears both as a standing starting price and inside a seasonal sale banner, so confirm which applies at intake.
What the price coversThe sale banner reads "Applied at Checkout" and the final price is confirmed at checkout. The tirzepatide price is the same at every dose. Whether the semaglutide price changes with dose is not stated on their site (checked 6 October 2026). No insurance is required.MEDVi states there is no membership or hidden fee on the compounded plans, that no insurance is required, that shipping is free and that the plans are HSA/FSA approved. Branded routes are sold as a $99 membership plus the cost of the medication.
MedicinesCompounded semaglutide and compounded tirzepatide. The site also lists branded options, which this page does not compare.Compounded GLP-1 injections and tablets, plus branded GLP-1 routes. MEDVi states that compounded medications are dispensed by state-licensed pharmacies but are not FDA approved.
Who decides on treatmentA short online quiz, then a clinician reviews the intake and decides whether treatment is appropriate. Not everyone qualifies. Welludr LLC provides technology and non-clinical administrative support; a licensed clinician makes all diagnosis and prescribing decisions using independent clinical judgment; a prescription is never guaranteed.Online assessment, then a consultation with an OpenLoop Health clinician after checkout, who determines eligibility and retains the prescribing decision.
PharmacyA licensed pharmacy dispenses if treatment is prescribed. Which pharmacy is not stated on their sign-up page (checked 6 October 2026).Three partner compounding pharmacies: Triad Rx, Red Rock Home Pharmacy and Beaker Pharmacy. Which one fills a given order is not stated.
CancellationMonthly plans can be cancelled or changed anytime.Cancellation must be received at least 72 hours before the next billing date. On a monthly plan there is no refund for the month of cancellation. A full refund applies if you cancel within the first 72 hours before receiving services, or if a clinician disqualifies you for a medical reason.
SupportProvider support, ongoing check-ins, progress tracking and messaging with clinicians are included, as Wellmedr describes them.MEDVi lists 24/7 support and free dietician visits and care coaching, the latter subject to insurance and copay eligibility.
AvailabilityUnited States. The states served are not listed on their sign-up page (checked 6 October 2026), and eligibility is checked during sign-up.Availability varies by state and clinical eligibility. MEDVi does not state which states it serves.
FDA warning letter on recordOur Wellmedr review records none. That is not a statement that none exists, so check the FDA's published letters yourself.On 20 February 2026 the FDA issued warning letter 721455 to MEDVi, LLC dba MEDVi, concerning the labelling and marketing of its compounded semaglutide and tirzepatide products. As of 25 September 2026 the FDA record showed no indication the matter had been closed (our MEDVi review).
Who each suitsPeople who want a published starting price and monthly plans they can cancel or change, and who accept that the sale price is promotional.Buyers who want the supply chain written down before they pay, and people weighing a compounded plan against a branded one on the same platform.

Who Should Choose Wellmedr vs MEDVi?

Wellmedr may suit you if

  • You want a published starting price for both medications and monthly plans you can cancel or change anytime
  • You accept that the price is a sale price and the final figure is confirmed at checkout
  • You are comfortable that the states served are not listed until you sign up

MEDVi may suit you if

  • You want the partner pharmacies, prescriber network and refund policy published in full
  • You want to compare a compounded plan with a branded one on the same platform
  • You have read the FDA warning letter on its record and are comfortable with it

Which should you choose?

Choose Wellmedr if a published starting price with monthly plans you can cancel or change matters most and you are comfortable that compounded medicines are not FDA approved. Choose MEDVi if published detail about pharmacies, prescribers and refund terms matters more to you, and read the FDA warning letter on its record first. Either way a clinician decides whether treatment is appropriate, so check your state and health history with each before you start.

Next step

Compare broader provider options

If you want to move beyond this one-to-one comparison, use the broader GLP-1 comparison page to compare pricing and support style across more providers.

Frequently asked questions

How much does Wellmedr cost compared with MEDVi?

Wellmedr advertises compounded semaglutide at $49 a month and tirzepatide at $89 a month during a fall sale, an advertised sale price whose plan cards say "Starting At" (checked 6 October 2026). The final price is confirmed at checkout. Both prices change, so confirm the current figure with each provider before you start.

Are Wellmedr's medications approved by the FDA?

Compounded medications are not FDA approved and are not evaluated by the FDA for safety or effectiveness. A licensed clinician reviews your intake and decides whether treatment is appropriate for you.

Who prescribes at Wellmedr, and is there a safety warning?

Welludr LLC provides technology and non-clinical administrative support; a licensed clinician makes all diagnosis and prescribing decisions using independent clinical judgment; a prescription is never guaranteed. Semaglutide and tirzepatide carry a boxed warning for the risk of thyroid C-cell tumours, including medullary thyroid carcinoma. They are not suitable if you or a close relative have had medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2), so tell the clinician about that history.

Why does the Wellmedr sign-up page say welludr.?

It is the same programme. Expect to see welludr. during sign-up, and Wellmedr in our review and on this page.

For clinics

Are you a clinic?

Get featured on this page and reach patients actively looking for peptide therapy, GLP-1 treatments, recovery support, and longevity care.